However, remdesivir and imatinib showed a trend toward improvement, which may indicate that they may be useful in a subgroup of patients.
← all excerpts
Predictors of Mortality among COVID-19 Patients Admitted to Intensive Care Units: A Single-Center Study in Tehran, Iran.
1
—
—